Awakn Life Sciences (TSE:AWKN) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Awakn Life Sciences Corp., a biotechnology company focused on addiction therapeutics, has secured an unsecured credit facility of up to $535,000 to support its ongoing research and development projects. This financial move helps the company maintain its momentum in reaching new milestones, particularly in its lead programs AWKN-001 and AWKN-002 targeting mental health disorders.
For further insights into TSE:AWKN stock, check out TipRanks’ Stock Analysis page.